AUTOINDUCTION OF 450191-S, A NEW SLEEP INDUCER OF 1H-1,2,4-TRIAZOLYL BENZOPHENONE DERIVATIVE, IN DOGS
スポンサーリンク
概要
- 論文の詳細を見る
Alterations of plasma metabolite profiles were studied following single or multiple oral administrations of 5-[(2-aminoacetamido) methyl]-1-[p-chloro-2-(o-chlorobenzoyl) phenyl]-N, N-dimethyl-1H-1,2,4-triazole-3-carboxamide hydrochloride dihydrate (450191-S) in Beagle dogs. In plasma, unchanged 450191-S was not detected, but active metabolite, 8-chloro-6-(2-chlorophenyl)-2-(N, N-dimethylcarbamoyl)-4H-1,2,4-triazolo [1,5-a] [1,4] benzodiazepine (M-1) appeared first, followed by four active metabolites that were hydroxylated or demethylated in the N, N-dimethylcarbamoyl side chain of M-1. At single doses of 5 to 50 mg/kg, the areas under the plasma concentration-time curves (AUCs) of the metabolites were linearly increased, showing that there was no saturable process in the steps of absorption, distribution, metabolism and excretion. After multiple administrations (50 mg/kg/d for 15 d), the same metabolites appeared in the plasma but the patterns of the plasma metabolite profiles were considerably different from those after single administrations. The peak plasma levels of M-1 and its hydroxylated metabolites in the carbamoyl side chain were attained more rapidly in the multiple administrations, demonstrating higher peak values compared to those in the single administrations, and the eliminations of these metabolites from plasma were also rapid. However, no difference in the values of the AUCs were observed between single and multiple administrations. With the other active metabolites, the peak plasma levels after multiple administrations were considerably lowered by rapid elimination, resulting in a marked decrease in AUCs. Cytochrome P-450 content and oxidative O-dealkylase activities in dog liver homogenates increased two to five times after a 15-d administration of 450191-S. We concluded from these results that hepatic drug-metabolizing enzymes were induced during multiple administrations of 450191-S in dogs, resulting in decreased plasma levels of its metabolites.
- 公益社団法人日本薬学会の論文
著者
-
Futaguchi Shinya
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Koike M
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Matsubara Takashi
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Koike Masahiro
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Touchi A
Shionogi & Co. Ltd. Osaka Jpn
-
Touchi Akira
Shionogi & Co. Ltd. Developmental Research Laboratories
-
SUGENO KOICHI
Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
Sugeno Koichi
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Matsubara Takashi
Shionogi Research Laboratories
関連論文
- Effects of Serum Albumin and Liver Cytosol on CYP2C9-and CYP3A4-mediated Drug Metabolism
- VITAMIN K-REVERSIBLE HYPOPROTHROMBINEMIA IN RATS: COMPARISON OF HYPOPROTHROMBINEMIC CHANGES IN VARIOUS STRAINS OF RATS CAUSED BY VITAMIN K DEFICIENCY AND ANTIBIOTIC TREATMENT
- BIOPHARMACEUTICAL CHARACTERIZATION OF 450191-S, A RINGOPENED DERIVATIVE OF 1,4-BENZODIAZEPINE. I. ACTIVE METABOLITE LEVELS IN RAT PLASMA
- EFFECT OF FOOD ON ABSORPTION OF 450191-S, A 1H-1,2,4-TRIAZOLYL BENZOPHENONE DERIVATIVE FROM RAT SMALL INTESTINE
- INTESTINAL ACTIVATION OF A NEW SLEEP INDUCER 450191-S, A 1 H-1,2,4-TRIAZOLYL BENZOPHENONE DERIVATIVE, IN RATS
- ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF A NEW SLEEP INDUCER, 450191-S, A 1H-1,2,4,-TRIAZOLYL BENZOPHENONE DERIVATIVE
- CARBON TETRACHLORIDE-INDUCED HEPATOTOXICITY IN RATS: EVIDENCE FOR DIFFERENT SUSCEPTIBILITIES OF RAT LIVER LOBES
- ALTERATION OF HEPATIC P-450 MONOOXYGENASE SYSTEM FOLLOWING ADMINISTRATION OF CARBON TETRACHLORIDE (The 6th Meeting for the Study of Toxic Effect)
- Sex Difference in Adrenergic Receptor-Mediated Glycogenolysis in Rat Livers
- Species and Sex Differences in the Inhibitory Action of the Corticosteroid Alclometasone Dipropionate on the Hepatic Drug-Metabolizing System
- Vitamin K-Reversible Hypoprothrombinemia in Rats I. Sex Differences in the Development of Hypoprothrombinemia and the Effects of Beta-Lactam Antibiotics
- BIOTRANSFORMATION OF COUMARIN DERIVATIVES (2) OXIDATIVE METABOLISM OF 7-ALKOXYCOUMARIN BY MICROSOMAL ENZYMES AND A SIMPLE ASSAY PROCEDURE FOR 7-ALKOXYCOUMARIN O-DEALKYLASE
- LIVER MICROSOMAL CYTOCHROME P-450-DEPENDENT O-DEALKYLATION REACTION IN VARIOUS ANIMALS
- AUTOINDUCTION OF 450191-S, A NEW SLEEP INDUCER OF 1H-1,2,4-TRIAZOLYL BENZOPHENONE DERIVATIVE, IN DOGS
- INDUCTION OF RAT LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES BY A NEW SLEEP INDUCER 450191-S AND PLASMA LEVELS OF 450191-S-METABOLITES
- HEPATIC AMINOPYRINE N-DEMETHYLASE SYSTEM: FURTHER STUDIES OF ASSAY PROCEDURE
- HETEROGENEOUS DISTRIBUTION OF THE CYTOCHROME P-450 MONOOXYGENASE SYSTEM IN RAT LIVER LOBES
- ALTERED BILE ACID METABOLISM IN ALLOXAN DIABETIC RATS
- UPTAKE OF 450191-S, A 1H-1,2,4-TRIAZOLYL BENZOPHENONE DERIVATIVE, IN THE EVERTED SAC OF RAT SMALL INTESTINE : ROLE OF INTESTINAL AMINOPEPTIDASES
- EFFECTS OF DEXAMETHASONE 17-ESTERS ON ADRENAL WEIGHT AND HYDROLYSIS OF GLUCOCORTICOID 17-ESTERS IN RAT FETUSES
- Effects of Alcohol-Metabolizing Enzyme Inhibitors and Beta-Lactam Antibiotics on Ethanol Elimination in Rats
- IDENTIFICATION OF NOVEL N-GLUCURONIDES IN RAT BILE AFTER ADMINISTRATION OF 450191-S, A 1H-1,2,4-TRIAZOLYL BENZOPHENONE DERIVATIVE
- HEPATIC AMINOPYRINE N-DEMETHYLASE SYSTEM: INTERACTION OF AMINOPYRINE WITH MICROSOMAL CYTOCHROME P-450
- BIOTRANSFORMATION OF COUMARIN DERIVATIVES (1) 7-ALKOXYCOUMARIN O-DEALKYLASE IN LIVER MICROSOMES
- HEPATIC AMINOPYRINE N-DEMETHYLASE SYSTEM: EFFECT OF CYANIDE ON MICROSOMAL N-DEMETHYLASE ACTIVITY
- DIURNAL VARIATION OF CARBON TETRACHLORIDE-INDUCED HEPATOTOXICITY AND HEPATIC DRUG-METABOLIZING ACTIVITY IN RATS
- Studies on oxacephem antibiotics: Comparison of the effects of 1-oxa and 1-thia cephalosporins on blood coagulation activities and vitamin K metabolism in rats.
- Cytochrome P-450-dependent monooxygenase activities in prenatal and postnatal human livers: Comparison of human liver 7-alkoxycoumarin O-dealkylases with rat liver enzymes.
- Hepatic 7-alkoxycoumarin O-dealkylase in mice: Induction by .BETA.-naphthoflavone of hepatic enzyme activity.
- Pharmacokinetics of latamoxef and N-methyltetrazolethiol in rats associated with the development of disulfiram-like effects.
- A comparative study on the effects of disulfiram and .BETA.-lactam antibiotics on the acetaldehyde-metabolizing system in rats.
- Effects of beta-lactam antibiotics and N-methyltetrazolethiol on the alcohol-metabolizing system in rats.
- Effects of adrenergic agonists and antagonists on glycogenolysis in isolated perfused rat liver.
- Vitamin K reversible hypoprothrombinemia in rats. II. Efficacy of vitamin K on latamoxef-induced coagulopathy in rats.
- In vitro effects of various heterocyclic thiol compounds and .BETA.-lactam antibiotics on vitamin K-dependent .GAMMA.-glutamylcarboxylation activity in liver microsomes.
- Effects of beta-lactam antibiotics on the acetaldehyde-metabolizing system in germ-free rats.
- Comparison of the action of epinephrine and a respiratory chain uncoupler, 2,4-dinitrophenol, on Ca2+-mobilization in isolated hepatocytes and perfused livers.
- In vitro effect of beta-lactam antibiotics and N-methyl-tetrazolethiol on microsomal vitamin K epoxide reductase in rats.
- Effect of change of hepatic drug-metabolizing activity on plasma concentrations of major metabolites of the new sleep inducer 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative.
- Effect of N-methyltetrazolethiol on liver microsomal gamma-glutamylcarboxylation. Modification of the in vitro action of N-methyltetrazolethiol.